The Valley Desk

NCT00568880 · Interventional trial

Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Overall registry status Completed

Phase 1

Conditions Multiple Myeloma and Plasma Cell Neoplasm

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov